The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Cassie Hill, partner at Mishcon de Reya, discusses rebuilding client relationships after maternity leave and the pressures facing women at a pivotal stage of their career
PE-backed practices now comprise the majority of ranked firms for patent prosecution in the Netherlands, but competitors are confident about their decision to remain independent
By accepting a relatively small sample of infringing content to grant worldwide relief, a UK court has adopted a pragmatic approach that could reduce the time and expense involved in huge enforcement actions
The expansion of the Patent Prosecution Highway network in Africa raises questions about South Africa’s potential participation, says Thandanani Cwele, with oversight from David Cochrane of Spoor & Fisher South Africa
Selin Sinem Erciyas of Gün + Partners examines whether the EU Pharma Package’s expanded Bolar exemption aligns with the TRIPS Agreement, drawing lessons from Türkiye’s long-standing pharmaceutical patent jurisprudence
Igor Charles and Théo Coquis of INLEX analyse a Paris Judicial Court ruling confirming that trademark exhaustion applies to bundled genuine products where the original packaging remains unaltered
